share_log

Spero Therapeutics | 8-K: Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Spero Therapeutics | 8-K: Current report

Spero Therapeutics | 8-K:重大事件
SEC announcement ·  03/13 16:11
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息